Early-stage venture firm dedicated to the creative act of building companies and long-duration founder partnerships.
Founded 2024
Type Venture capital 1 Debut Fund 2024-09-05 2024-09-05 $55M Official letter confirms USD55m raised debutfund, numericdate08/05/24 ambiguous; AxiosSeptember5,2024 publicreport corroborates capital, not exactlegalfinalclose.
SHOW MORE
$2M $500K – $5M London $1M $1M – $2M New York, New York $1M $1M – $2M New York, New York — — – —
SHOW MORE
team@apexlogos.ai · 18 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size and investment stages
| Item | Evidence and interpretation |
| --- | --- |
| Debut fund / Fund I, 2024 vintage | **US$55m raised**, explicitly stated by the official founding letter. Its displayed date is `08/05/24`; the numeric format is preserved because it is not explained. Axios reported US$55m raised for the debut fund on **2024-09-05**. This is raised capital, not merely a target; no separate legal final-close date was established. [S2, S6] |
| Continuing confirmation | Regent stated that Asylum had a US$55m fund in an interview published **2026-01-20**. [S5] |
| Initial check size | Official launch policy: **US$1–2m** for early-stage founders. This is a check range, not total fund assets or individual-round size. [S2] |
| Newer funds | Searches for 2025/2026 funds and “Fund II” did not establish a newer independently verified fund announcement. The US$55m debut fund is therefore **latest-known**, not conclusively the latest. |
| Regulatory-data leads | Fundraising Fox reports gross asset values of US$54.2m for `ASYLUM VENTURES 2024, LP` and US$1.1m for `ASYLUM VENTURES 2024-A, LP`, dated February 2026, citing ADV/EDGAR. These underlying records were not independently retrieved here; do not treat two vehicles as two sequential funds or substitute their AUM for committed fund size. [S7] |
Current strategy is early/inception stage: the official launch letter supports early-stage investments, and the January 2026 COO interview confirms inception/pre-seed emphasis. The official portfolio assigns pre-seed or seed roles throughout. Signal's person-level later-stage tags do not establish a current Asylum Series A/B mandate. [S1, S2, S4, S5]
Sources and access
All sources accessed **2026-10-06**. Undated pages are identified as such; public statements and directory listings are not auditing evidence.
| ID | URL / source | Publication date and access notes |
| --- | --- | --- |
| S1 | https://signal.nfx.com/firms/asylum-ventures | Undated; directly readable, intro paths gated. |
| S2 | https://www.asylum.vc/origins | Official founding letter, displays `08/05/24`; directly read. |
| S3 | https://www.asylum.vc/team | Undated official team page; directly read. |
| S4 | https://www.asylum.vc/companies | Undated official portfolio; directly read; claims do not supply transaction dates. |
| S5 | https://www.brventurefund.com/a-conversation-with-mackenzie-regent-coo-and-founding-partner-at-asylum-ventures | 2026-01-20; direct published interview with firm COO. |
| S6 | https://www.axios.com/newsletters/axios-pro-rata-2e2b835c-97d4-4598-975c-381cc3be700e | 2024-09-05; search-index accessible; direct open failed. |
| S7 | https://fundraisingfox.com/investors/asylum-ventures | Undated; index says last verified 2026-09-29; underlying regulatory records not independently checked. |
| S8 | https://ark-robotics.com/ | Undated official company site; directly read. |
| S9 | https://nordic9.com/news/ark-robotics-in-a-seed-round-with-inflection-adjacent-asylum-ventures-belief-capital-and-np-hard-ventures/ | 2025-07-01; indexed funding summary, further details gated. |
| S10 | https://pantograph.com/ | Undated official company site; research entry dated 2026-09-17; directly read. |
| S11 | https://www.recastsystems.com/ | Undated official company site; 2026 season section; directly read. |
| S12 | https://aranya.tech/ | Undated official technical company site; directly read. |
| S13 | https://www.citybiz.co/article/897254/aranya-raises-11-million-to-scale-ai-infrastructure-platform/ | September 2026 per index; initial open readable, later retry timed out; exact publication day not established. |
| S14 | https://www.priorcomputers.ai/ | Undated official company site; substantive text readable despite JavaScript notice. |
| S15 | https://www.linkedin.com/posts/kian-sadeghi-8273ba178_nucleus-genomics-announces-14-million-in-activity-7290753506074845187-ExGS | January 2025 announcement (public post shows relative date); directly read. Linked company announcement https://mynucleus.com/articles/fundraise-2025 failed to open. |
| S16 | https://arcxp-prod.genomeweb.com/informatics/nucleus-genomics-raises-14m-series-financing | 2025-01-31; search-index article accessible with investor list. |
| S17 | https://www.concentricsilicon.com/ | Undated official company site; directly read. |
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| Debut Fund | USD 55000000 | 2024-09-05 | SHOW MORE
team@apexlogos.ai · 19 hours ago
Match research 2026-10-06 / AsylumVentures / sha256:d31685d2543e7da844fba1ad8f3c6a8488a015673c9428c269c19dcc681b3969 / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
Prior Computers' cognitive-science framing and Asylum's “machine psychology” description refer to AI research; no neural recording, stimulation, BCI, brain imaging or nervous-system interface was established. Nucleus's genetics and neurological/behavioral risk analysis remain genomics, not direct neurotechnology. A search-index mirror of Wajskop's LinkedIn surfaced liked/reposted Precision Neuroscience content; social engagement does not establish investment, and no firm-attributed Precision transaction was verified. Do not import partners' prior-firm portfolios or social posts into Asylum's neurotech history. [S4, S14–S16]
## Concrete review notes for a later Adex agent
1. Add the raised US$55m debut fund, 2024 vintage, with the official launch letter and September 2024 announcement; label as latest-known. Keep fund commitment and the US$1–2m official initial check policy separate from Signal's personal ranges.
2. Review stage and lead flags against the official portfolio: Aranya, Danger Testing, Hilbert's AI, Homefig, Noso, Prior Computers, Riffle and Super Games are pre-seed leads; Pantograph and Kanurra are pre-seed co-leads; Concentric is seed co-lead; Ark is Seed II lead; Recast and Clearing are seed supporting. The baseline's blanket `isLead:false` conflicts with several explicit claims. Dates remain unknown unless supported elsewhere. [S4]
3. Consider Nucleus Genomics as a missing participation supported by its founder's announcement; check identity and round date before adding it. [S15, S16]
4. Review team roles, especially Regent's COO/founding-partner role and Wu's unresolved current status; do not invent an end date. [S3, S5]
5. Deep-tech evidence is strongest for Ark, Pantograph and Recast. Preserve uncertainty for Prior and distinguish Aranya's systems infrastructure and Nucleus's genomics from direct neurotech. Do not classify Concentric as a semiconductor innovator based on its name.
6. Investigate underlying ADV/Form D vehicles before any fund/AUM update. Reconcile Aranya's dated US$9m seed against US$11m combined financing; avoid conflating totals and transaction amounts.
## Sources and access
All sources accessed **2026-10-06**. Undated pages are identified as such; public statements and directory listings are not auditing evidence.
| ID | URL / source | Publication date and access notes |
| --- | --- | --- |
| S1 | https://signal.nfx.com/firms/asylum-ventures | Undated; directly readable, intro paths gated. |
| S2 | https://www.asylum.vc/origins | Official founding letter, displays `08/05/24`; directly read. |
| S3 | https://www.asylum.vc/team | Undated official team page; directly read. |
| S4 | https://www.asylum.vc/companies | Undated official portfolio; directly read; claims do not supply transaction dates. |
| S5 | https://www.brventurefund.com/a-conversation-with-mackenzie-regent-coo-and-founding-partner-at-asylum-ventures | 2026-01-20; direct published interview with firm COO. |
| S6 | https://www.axios.com/newsletters/axios-pro-rata-2e2b835c-97d4-4598-975c-381cc3be700e | 2024-09-05; search-index accessible; direct open failed. |
| S7 | https://fundraisingfox.com/investors/asylum-ventures | Undated; index says last verified 2026-09-29; underlying regulatory records not independently checked. |
| S8 | https://ark-robotics.com/ | Undated official company site; directly read. |
| S9 | https://nordic9.com/news/ark-robotics-in-a-seed-round-with-inflection-adjacent-asylum-ventures-belief-capital-and-np-hard-ventures/ | 2025-07-01; indexed funding summary, further details gated. |
| S10 | https://pantograph.com/ | Undated official company site; research entry dated 2026-09-17; directly read. |
| S11 | https://www.recastsystems.com/ | Undated official company site; 2026 season section; directly read. |
| S12 | https://aranya.tech/ | Undated official technical company site; directly read. |
| S13 | https://www.citybiz.co/article/897254/aranya-raises-11-million-to-scale-ai-infrastructure-platform/ | September 2026 per index; initial open readable, later retry timed out; exact publication day not established. |
| S14 | https://www.priorcomputers.ai/ | Undated official company site; substantive text readable despite JavaScript notice. |
| S15 | https://www.linkedin.com/posts/kian-sadeghi-8273ba178_nucleus-genomics-announces-14-million-in-activity-7290753506074845187-ExGS | January 2025 announcement (public post shows relative date); directly read. Linked company announcement https://mynucleus.com/articles/fundraise-2025 failed to open. |
| S16 | https://arcxp-prod.genomeweb.com/informatics/nucleus-genomics-raises-14m-series-financing | 2025-01-31; search-index article accessible with investor list. |
| S17 | https://www.concentricsilicon.com/ | Undated official company site; directly read. | SHOW MORE
team@apexlogos.ai · 19 hours ago
Match research 2026-10-06 / AsylumVentures / sha256:d31685d2543e7da844fba1ad8f3c6a8488a015673c9428c269c19dcc681b3969 / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# Asylum Ventures
- **Exact Adex ID:** `AsylumVentures`
- **Canonical Adex URL:** https://adex.page/firms/AsylumVentures
- **Research date:** 2026-10-06
- **Scope:** Research handoff only; no Adex or database changes made.
Asylum is a Brooklyn/New York venture firm launched in 2024. Its latest-known verified fund is the **US$55 million debut fund**, and its published initial investment range is **US$1–2 million**. Its current public portfolio concentrates on pre-seed and seed transactions and includes technically substantive robotics and weather-modification companies. **No verified neurotech investment found in the sources checked.** The official founding letter, current portfolio, and January 2026 interview with its COO support these conclusions. [S2–S5]
## Adex baseline and NFX Signal
The exact-ID snapshot, `data/research/_sources/AsylumVentures.adex.json`, was retrieved from read-only Adex MCP Search on 2026-10-06. It describes an early-stage firm supporting company creation and long founder relationships, founded in 2024, located in New York. It supplies official home, team and portfolio links plus Signal. Its investor profile has null check minimum, maximum and sweet spot. Listed people are Mackenzie Regent (partner), Nicholas Chirls (Investor), Lola Wajskop (partner), and Jonathan Wu (investor).
Fourteen baseline investment entries are Aranya, Ark Robotics, Concentric, Danger Testing, Hilbert's AI, Homefig, Kanurra, Noso, Pantograph, Prior Computers, Recast, Riffle, Super Games and The Clearing Company. All lack transaction dates, round amounts and stages; all have `isLead: false`. Their evidence is a portfolio-page claim accessed 2026-09-14, so these are not fourteen independently established financing announcements.
**NFX Signal was directly read**, rather than only viewed through search results, at https://signal.nfx.com/firms/asylum-ventures on 2026-10-06. It lists founding year 2024, New York/Brooklyn/London locations, and investor cards for Regent, Wajskop and Wu. Regent and Wu each have a US$1–2 million range and US$1.5 million sweet spot; Wajskop has US$0.5–5 million and US$2.8 million. Signal tags span seed/Series A and, for Wajskop, Series B across multiple sectors including hardware. These are individual directory-profile claims, not a verified firm mandate. Introductions require sign-in. [S1]
The official current team page lists **Nicholas Chirls, Mackenzie Regent and Lola Wajskop**, and describes a small New York partnership with long-duration founder relationships. It does not list Jonathan Wu. The January 2026 interview also describes three people and identifies Regent as COO and founding partner. Treat Wu's status and any London office as unresolved, rather than overwriting them solely from directory evidence. Chirls's Notation/betaworks history and Wajskop's Hummingbird history must be kept separate from Asylum investments. [S3, S5]
## Fund size and investment stages
| Item | Evidence and interpretation |
| --- | --- |
| Debut fund / Fund I, 2024 vintage | **US$55m raised**, explicitly stated by the official founding letter. Its displayed date is `08/05/24`; the numeric format is preserved because it is not explained. Axios reported US$55m raised for the debut fund on **2024-09-05**. This is raised capital, not merely a target; no separate legal final-close date was established. [S2, S6] |
| Continuing confirmation | Regent stated that Asylum had a US$55m fund in an interview published **2026-01-20**. [S5] |
| Initial check size | Official launch policy: **US$1–2m** for early-stage founders. This is a check range, not total fund assets or individual-round size. [S2] |
| Newer funds | Searches for 2025/2026 funds and “Fund II” did not establish a newer independently verified fund announcement. The US$55m debut fund is therefore **latest-known**, not conclusively the latest. |
| Regulatory-data leads | Fundraising Fox reports gross asset values of US$54.2m for `ASYLUM VENTURES 2024, LP` and US$1.1m for `ASYLUM VENTURES 2024-A, LP`, dated February 2026, citing ADV/EDGAR. These underlying records were not independently retrieved here; do not treat two vehicles as two sequential funds or substitute their AUM for committed fund size. [S7] |
Current strategy is early/inception stage: the official launch letter supports early-stage investments, and the January 2026 COO interview confirms inception/pre-seed emphasis. The official portfolio assigns pre-seed or seed roles throughout. Signal's person-level later-stage tags do not establish a current Asylum Series A/B mandate. [S1, S2, S4, S5]
## Previous deep-tech investments
Firm attribution below comes from Asylum's **current official portfolio**; technical rationale is independently grounded in the investee's official website. Except where separately dated, transaction dates and amounts remain undisclosed. Classification is an analytical judgment, not a category claimed by every company. [S4]
| Company | Technical rationale and qualification | Firm attribution / round evidence |
| --- | --- | --- |
| **Ark Robotics** | Clear robotics/deep-tech evidence: networked collaborative autonomy, drone/server hardware, mission-control software, and autonomous ground robots. The official site describes operation across robotic systems and deployment in Ukraine. [S8] | Asylum lists **Seed II lead**, with no date or amount. Nordic9 reports a **US$7.5m seed round, 2025-07-01**, naming Asylum alongside other investors. It is uncertain whether that dated announcement is the same transaction as the current Seed II label. Do not conflate Ark with ARX Robotics, Arbe, ARK Invest, or Asylon. [S4, S9] |
| **Pantograph** | Clear research-driven robotics: the company develops generally intelligent robots, robotics models and its Pandroid hardware. Its public research includes a robotics benchmark dated **2026-09-17**. [S10] | **Pre-seed co-lead** per Asylum; date, amount and independent financing announcement not found. [S4] |
| **Recast Systems** | Clear applied-science/hardware case: precision weather modification combining atmospheric modeling, organic seeding materials, aerosolization equipment, sensors and field operations. Official site reports completed 2026 seasonal operations. [S11] | **Seed supporting** per Asylum; date/amount undisclosed in sources read. [S4] |
| **Aranya** | Technical AI-compute infrastructure: distributed operating-system and GPU-orchestration technology spanning drivers and federated clusters. This is substantive systems engineering, though hardware/cloud infrastructure is a broader deep-tech boundary than original semiconductor research. [S12] | **Pre-seed lead** per Asylum. September 2026 reporting describes **US$11m combined financing, including a US$9m seed** led by First Round with Asylum participating. Do not record US$11m as the seed alone. Secondary sources differ on announcement/transaction dates; independent round-date confirmation remains needed. [S4, S13] |
| **Prior Computers** | Candidate frontier-AI research investment: official site describes human-like intelligence and a team spanning deep learning and cognitive science. Public technical detail is sparse, so deep-tech classification is provisional. [S14] | **Pre-seed lead** per Asylum; date/amount undisclosed. [S4] |
| **Nucleus Genomics** | Biotechnology/genomics adjacent to the requested areas: genome interpretation and genetic-risk software, with sequencing performed through external services. Relevant to computational biology, but not evidence of original neural-interface technology. [S15, S16] | Founder Kian Sadeghi's public announcement directly names Asylum as a new investor in the **US$14m Series A**, bringing total financing to US$32m. GenomeWeb's **2025-01-31** report corroborates investor participation. This company is absent from the fourteen-entry Adex baseline/current Asylum public portfolio read. [S15, S16] |
**Excluded from a firm deep-tech conclusion:** Concentric Silicon is explicitly a semiconductor **distributor**, with quantitative inventory management and inspection facilities; its seed co-lead listing does not establish chip design or fabrication investment. Hilbert's AI, Homefig and the other application/service portfolio companies were not labeled deep tech merely for using AI or software. [S4, S17]
## Previous neurotech investments
**No verified neurotech investment found in the sources checked.** Searches included Asylum with neurotech, brain, neural and Precision Neuroscience, plus its official portfolio and the companies above. The finding is bounded by public-source coverage and does not establish that no such investments exist. SHOW MORE
team@apexlogos.ai · 23 days ago
MATCH 
Founders FundNucleus Genomics$14M · 2025-01-30
The Clearing Company
Ark Robotics
Aranya